Coherus Biosciences | CHRS - Interest Expense On Debt

Coherus Biosciences reported $9.38M in Interest Expense on Debt for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Interest Expense On Debt Change
ALKERMES ALKS:US USD 4.77M 1.22M
Alnylam Pharmaceuticals ALNY:US USD 29.91M 11.17M
Amgen AMGN:US USD 415M 47M
Baxter International BAX:US USD 125M 16M
Biogen BIIB:US USD 54.8M 5.1M
Biomarin Pharmaceutical BMRN:US USD 3.63M 1.05M
Bristol Myers Squibb BMY:US USD 294M 5M
Coherus Biosciences CHRS:US USD 9.38M 1.84M
Endo International Ordinary Shares ENDP:US USD 74.93M 65M
Fujifilm 4901:JP JPY 752M 181M
Gilead Sciences GILD:US USD 227M 2M
Ironwood Pharmaceuticals IRWD:US USD 1.53M 2K
JAZZ PHA JAZZ:US USD 81.22M 2.52M
Myriad Genetics MYGN:US USD 900K 100K
Pacira Pharmaceuticals PCRX:US USD 11.04M 1.18M
Pfizer PFE:US USD 313M 2M
Ptc Therapeutics PTCT:US USD 25.9M 6.42M
Regeneron Pharmaceuticals REGN:US USD 17.4M 2.1M
Revance Therapeutics RVNC:US USD 3.75M 3.16M
Sarepta Therapeutics SRPT:US USD 6.69M 8.05M
Teva Pharmaceutical TEVA:IT USD 237M 7M
Vertex Pharmaceuticals VRTX:US USD 11.6M 2.1M
Zoetis ZTS:US USD 62M 9M